Proteoglycans (PGs) are extracellular and cell surface-associated macromolecules that regulate cell adhesion, cell growth, matrix formation, and bind growth factors. In this work we studied the distribution of core proteins of four PGs (decorin, biglycan, a large molecular weight PG, and CD44) in human gingiva and periodontal ligament by immunohistochemical staining of frozen tissue sections with specific antibodies. Decorin, a major PG of this tissue, was localized on collagen fibex bundles in the gingival and periodontal connective tissues. Staining for decorin was most intense at the subepithelial region. Biglycan was a minor PG component of the human periodontium, showing some accumulation in connective tissue under the oral epithelium. At the immunohistochemical level, biglycan appeared to form fine filament-like structures on extracellular matrix fibers. Localization of large molecular weight PG differed from that of decorin and biglycan. It was concentrated in deep connective tissue areas of the gingiva and in the periodontal ligament, and was only weakly present at the subepithelial region. CD44 was mainly concentrated in cell-cell contact areas of basal and spinous layers of oral epithelium. In the connective tissue of gingiva and periodontal ligament, CD44 was localized on fibroblast cell surfaces. Connective tissue area under the junctional epithelium contained relatively small amounts of PGs. The results indicate that different parts of human periodontium contain a typical variety of PGs, suggesting a specific function for each PG species in the location at which they accumulate. (JHistochem Cyto chem 4 1 :1689-1699, 1993 ) KEY WORDS: Proteoglycans; Human periodontium; Immunohistochemistry. Literature Cited 1. Ruoslahti E. Structure and biology of proteoglycans. Annu Rev Cell Biol 1988;4:229 2. Krusius T, Ruoslahti E. Primary structure of extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci USA 1986;83:7683 3. Fisher LW, TermineJD, Young MF. Deduced protein sequence of bone small proteoglycan (biglycan) shows homology with proteoglycan I1 (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 1989;264:4571 Figure 5. Immunohistochemical staining of chondroitinase ABC pre-treated frozen hard tissue sections of human periodontal tissues from a 22-year-old woman with antibodies against protein cores of (A) decorin, (6) large molecular weight proteoglycan, and (C) CD44. (0) Control sample was reacted with non-immune serum. E, enamel; JE, junctional epithelium; OE, oral epithelium; R. root surface; PL, periodontal ligament; CT, connective tissue; B, bone. Original magnification x 91. Bar = 50 pm.
Introduction
Proteoglycans (PGs) are a group of cell surface and extracellular matrix macromolecules composed of a protein core to which one or more glycosaminoglycan (GAG) chains are attached. They regulate cell adhesion, cell growth, extracellular matrix formation, collagen fibril formation, and bind growth factors (1). The principal PGs of soft connective tissues are two low molecular weight chondroitin sulfate/dermatan sulfate PGs, a large molecular weight chondroitin sulfate/dermatan sulfate PG, and an integral cell membrane glycoprotein named CD44. Core protein sequences of some of the PGs in various connective tissues, i.e., decorin (2). biglycan (3, 4) , versican (S), and CD44 (6), have been obtained by cloning the corresponding cDNAs. of Dentistry, U. of Turku, Lemmink~senkatu 2, 20520 Turku, Finland. and NIH/NIDR BRSGRR05300, S15-DE 099275, R03 DE 09134, and RO1 Decorin (also known as PGII) is found in many connective tissues including skin, tendon, articular cartilage, bone (7-9), and gingiva (10). It binds to fibrillar collagens and inhibits collagen fibrillogenesis in vitro (11). In addition to collagens, a variety of other proteins have decorin-binding properties. They include among others fibronectin (12, 13) , transforming growth factor-p (14), and a high-affinity cell surface receptor on human osteosarcoma cells and fibroblasts, which mediates endocytosis of the PG (15). Decorin is the major PG secreted by cultured fibroblasts in vitro (16) (17) (18) . In cell culture, decorin is co-localized with fibronectin in the extracellular matrix (13), and it can inhibit cell adhesion on fibronectin (12) and cell growth (19) .
Biglycan (also known as PGI) is found in adult (3) and developing tissues, including bone and cartilage, and in some specialized cells such as skeletal myofibers, keratinocytes, and endothelial cells (9). In culture, cells from bone (3, 20) , skin (3), periodontal ligament (3,21), and gingiva (22) express mFWA for biglycan. Unlike decorin, biglycan has not been demonstrated to associate with collagen.
A large molecular weight PG with chondroitin sulfate/dermatan sulfate chains has been isolated from several sources (see 23 T for review). Its protein structure is very similar to that of aggregating PGs from bovine nasal cartilage. It has a protein core of approximately 300,000 KD with distinct domains at the amino and carboxyl termini. However, the complete protein sequences of these PGs are not known. An interesting large molecular weight PG synthesized by lung fibroblasts, named versican, has been cloned and sequenced. The deduced amino acid sequence of the core protein contains several functional domains. It has EGFand lectin-like sequences as well as a hyaluronic acid-binding region and a complement regulatory protein-like domain ( 5 ) . In cell cultures the large molecular weight PG is co-localized with fibronectin in the extracellular matrix (24,25). It has been suggested to function in cell recognition, possibly by connecting extracellular matrix molecules and cell surface glycoproteins (23).
CD44s are a broad class of integral membrane glycoproteins expressed on the surface of many cell types, including hematopoetic and epithelial cells, fibroblasts, and brain tissue (26). CD44 can function either in linking cells to extracellular matrix molecules such as hyaluronic acid (27) or collagen (28) or in intercellular adhesion (29). In fibroblasts, CD44 represents a chondroitin sulfate PG. The major form has a molecular mass of about 90,000 (26). Keratinocytes express CD44 core protein, which contains extra amino acids due to an additional exon in the coding gene. In keratinocytes CD44 contains heparan sulfate side chains (30).
Previous studies have established that GAGS and PGs are indeed present in the gingival tissues (see 31-33 for references). However, these studies have been preliminary and detailed localization has not been reported. Our previous studies have demonstrated that the major PGs expressed by human periodontal fibroblasts in culture are decorin, versican (large molecular weight PG), heparan sulfate PGs, and CD44 ( 1 8~4 ) .
Interestingly, despite considerable sequence homology of biglycan with decorin (3), expression of biglycan in periodontal cells seems to be relatively low (22). Given the importance of the many possible functions of these PGs in regulation of cell behavior and tissue structure, we have used specific antibodies to localize them in human periodontal tissues.
Materials and Methods
Histological Specimens. Biopsies for frozen sections of gingiva were obtained from 14 male and female volunteers (ages 16-85 years, mean 48.1 years). Biopsies were takcn from clinically healthy marginal gingivae around teeth of upper and lower jaws during tooth extraction or during surgical treatment of periodontal disease. For hard tissue frozen sections, a biopsy of periodontal tissues containing marginal gingiva, periodontal ligament, tooth, and alveolar bone was obtained from a healthy female volunteer (age 22 years) during extraction of the upper third molar. Samples were immediately frozen in liquid nitrogen. After sectioning, soft tissue samples were mounted on glass and fixed in 96% methanol at -2O'C. Hard tissue sections were mounted on plastic tape (3M #688) before fixation. Absence of inflammation was confirmed by histological staining of a section of each sample. The procedures were in accordance with the ethical standards of the Committee on Human Experimentation of the University of Turku.
Antibodies. Antibodies to various PGs used in this study were: (a) a polyclonal anti-peptide antibody against decorin core protein epitopes (2), which has previously been shown to recognize decorin in immunoprecipitations and Western immunoblots ofperiodontal cells (18); (b) a polyclonal antibody recognizing biglycan, raised against a synthetic peptide corresponding to an amino acid sequence near the NH2 terminus of the core protein (LF15) (3), which has been used to recognize biglycan core protein in various human tissues (9); (c) a monoclonal antibody (MAb) recognizing cell surface CD44 (also called Hermes-3), which has been previously characterized and properties described (35); and (d) MAb 5D5, which recognizes the protein core of large molecular weight aggregating PGs from sclera, tendon, bovine aorta, (Rahemtulla et al., manuscript in preparation) , and bovine gingiva (36). This antibody also recognizes the large PG synthesized and secreted by periodontal fibroblasts (18). large aggregating PGs from rat and human brain tissues (37-39), and PGs of rat predentin (40).
Immunohistochemical Staining. Immunohistochemical stainings were performed basically as described previously (9). Briefly, to expose antigenic sites in PG core proteins, sections were treated with 1.25 U/ml of chondroitinase ABC from Pmterrr vulgmi (Seikagaku Kogyo; Tokyo, Japan) in 0.5 mollliter Tris, 0.05 mollliter sodium acetate buffer, pH 7.2, containing 0.01% bovine serum albumin (BSA), at 37'C for 10 min. Sections were then treated with 0.3% Hz02 for 30 min and washed with PBS, pH 7.4. To inhibit nonspecific staining, the specimens were exposed to a 1:5 dilution of horse serum in PBS for 30 min at room temperature. Sections were then incubated with k100 dilution of antibodies recognizing PG core proteins or with normal rabbit or mouse serum (1:lOO) in PBS containing 0.1% BSA for 2 hr. After washing four times for 10 min with PBS-Triton X-100 (0.01%). sections were incubated with 1100 dilution ofperoxidas-conjugated swine anti-rabbit (Dakopatts; Glosuup, Denmark) or sheep anti-mouse (Boehringer Mannheim Biochemicals; Indianapolis, IN) antibodies for 30 min. PGs were visualized in a reaction with nickel-modified 3.3'-diaminobenzidine and H202 as described elsewhere (41) and counterstained with hematoxylinleosin as needed. Representative areas in the sections were then photographed with a microscope equipped with a photoautomat.
In a set of stainings, sections were incubated for 60 min with antiserum against decorin (1:lOO) or MAb 5D5 (ascites, 1:lOO) in PBS containing 1 mg/ml BSA, rinsed several times with PBS, and exposed to rhodamineconjugated goat anti-rabbit or anti-mouse IgG (1:lOO) (Boehringer Mannheim) for 60 min. Localization of CD44 was performed as above except that non-diluted hybridoma supernatant was used as the primary antibody. After rinsing, specimens were mounted in PBS containing 1 mglmlp-phenylenediamine (Sigma; St Louis, MO) to avoid photobleaching (42). AImost identical results were obtained whether the samples were treated or left untreated with chondroitinase ABC (data not shown).
Relative amounts of decorin and large molecular weight PG in human periodontium were measured by a technique previously described (43) . Briefly, the intensity ofimmunotluorescence was mcasured in different areas of the section with a photoautomat connected to a microscope (Nikon HFX-IIA). The exposure time was measured and converted to its reciprocal value. The reciprocal value obtained for stainings of sections with non-immune antibody was then subtracted. Results were expressed as means * SD of the five different measurements from each site of three sections. 
Results
ized in the phase-contrast images of the standard sections ( Figure   Antibodies against decorin and large molecular weight PG showed that these two molecules were distributed throughout human gingival connective tissue. It should be noted that MAb 5D5 against large molecular weight PG showed slight crossreactivity to epithelium ( Figure IA) . Similar staining has also been observed for human skin (results not shown). The significance of this crossreactivity to the epithelial layer is not known, since the PGs of gingival epithelium are of heparan sulfate type (44) and human keratinocytes in culture synthesize relatively small PGs (45) . However, we cannot rule out the possibility that this crossreactivity is due to nonspecific binding or that an epitope exists in the epithelial PGs that is recognized by MAb 5D5. Further work is needed to clarify this problem.
The distribution of large molecular weight PG and decorin within the tissue was quite different. Large molecular weight PG was concentrated in the deep connective tissue areas (Figure lA) , whereas decorin accumulated at a subepithelial location ( Figure  IC) . We compared the distribution of large molecular weight PG and decorin in subepithelial and deep connective tissue areas by measuring the relative staining intensities of these PGs. Expression of large molecular weight PG was approximately threefold higher in the deep connective tissue than in more superficial areas ( Figure 1B) . In contrast, the staining for decorin was markedly more intense in the subepithelial region than in deeper areas ( Figure 1D ).
Antibodies to decorin intensely stained the basement membrane zone (Figure 2A) . The vicinity of the basement membrane was not stained with antibodies against large molecular weight PG ( Figure  2B ). In connective tissue decorin was co-localized with collagen fiber bundles ( Figure 2C ), whereas large molecular weight PG was localized between the fibers ( Figure 2D) .
The staining intensity of antibodies against biglycan indicated that this molecule was a minor component of human gingival tissue. Biglycan core protein epitopes showed some accumulation in connective tissue under the epithelial rete ridges ( Figure 3A ). This antibody showed slight crossreactivity with the epithelium. However, in control experiments where nonspecific rabbit serum was used a similar pattern of staining was observed ( Figure 3B ). In sections stained with fluorescence-coupled secondary antibodies, no staining of the epithelium was seen (data not shown). At a higher magnification, biglycan was localized in the matrix as fine, filamentlike structures ( Figure 3C ). In control experiments with nonspecific rabbit serum these structures were not observed. Figure 4A shows a phase-contrast image of the gingival tissue, examined by immunofluorescence in Figure 4B . In the oral epithelium, CD44 was concentrated in basal and spinous layers, where it was localized mainly in cell-cell contact areas ( Figures 4B-4D) . The intercellular spaces of the stratum corneum were always negative. A dot-like pattern in the stratum spinosum suggested localization of CD44 between desmosome-like structures that were visual-4D). In the basal layer, CD44 was present at the lateral cell contacts only and was missing at basal cell membranes facing the basement membrane zone ( Figures 4B and 4E ). Gingival connective tissue fibroblasts stained strongly for CD44, showing a streak-like distribution (Figures 4E and 4F) .
To further analyze the distribution of PGs in human periodontal tissues, we used frozen hard tissue sections. The results are illustrated in Figure 5 . Decorin was expressed throughout the connective tissue ( Figure TA) . It accumulated under the oral epithelium, where it was co-localized with collagen fiber bundles. Decorin was also intensively stained around collagen fibers in the periodontal ligament (compare Figures 5A and 5D ). Large molecular weight PG was localized in the periodontal ligament area and near the alveolar bone. The area under the oral epithelium showed only a moderate reaction, confirming our previous results with soft tissue specimens ( Figure 5B ). CD44 was expressed throughout periodontal connective tissue. Intense staining was seen over fibroblasts in the periodontal ligament and gingiva. The basal and spinous layers of gingival epithelium showed positive staining for CD44, whereas the junctional epithelium demonstrated only a weak positive reaction ( Figure 5C ). Staining for biglycan in hard tissue sections gave only a weak positive signal that was hardly distinguishable from the negative control stainings (data not shown).
Discussion
In biochemical studies of gingival connective tissue and epithelium, three different PG species have been identified, i.e., dermatan sulfate, chondroitin sulfate, and heparan sulfate PGs. The major component was a small dermatan sulfate PG (44), now known as decorin.
In the present study we used immunohistochemical techniques to identify and localize PGs of periodontal tissues. We used specific antibodies to demonstrate the presence of decorin, biglycan, a large molecular weight PG, and CD44 in human periodontal tissues. Our results show that decorin was distributed throughout the gingival connective tissue, where it was localized over collagen fiber bundles. Staining was most intense at the subepithelial location. Several other studies have demonstrated that decorin is localized to the same region in human dermis (9, 46, 47) . Furthermore, similar localization of dermatan sulfate GAG in human gingiva has been reported (48, 49) . Fibroblasts cultured from papillary dermis seem to secrete greater amounts of decorin compared with reticular fibroblasts (IO), and we have previously demonstrated that cloned human periodontal fibroblasts produce differentially glycosylated decorin isotypes (18). These observations suggest that elevated levels of decorin in the subepithelial region of the gingival tissue could result from synthetic activities of a phenotypically unique fibroblast population within that region.
Decorin can bind collagen Types I-VI in vitro, with the highest affinity for Type VI collagen (51), and since Types I11 and VI collagen are concentrated in subepithelial connective tissue of gingiva (52-54) it is not surprising that decorin is also concentrated in that region, as shown in the present study. Decorin can regulate collagen fiber assembly (11), and our results on localization of decorin in conjunction with collagen bundles in gingiva suggest a similar function for decorin in this connective tissue. Decorin also stained intensely the basement membrane zone. A similar staining pattern has been reported in skin with an antibody against small chondroitin sulfate/dermatan sulfate PG (46). These findings suggest Biglycan has been demonstrated in developing tissues and on cell surfaces of some specialized cells (9). In adult tissue expression of biglycan is almost undetectable (47) . In cell culture, gingival fibroblasts express low levels of biglycan mRNA (22), whereas expression of biglycan mRNA in periodontal ligament fibroblasts is higher ( 3 3 ) . Biglycan expression can, however, be stimulated by transforming growth factor-B (22). In the present study we observed that biglycan was only weakly expressed in gingival tissues, showing some accumulation in the connective tissue under epithelial rete ridges. In this region biglycan was localized as fine filaments on extracellular matrix fibers. The physiological role of biglycan is not fully understood, and collagen-binding properties of biglycan have not been demonstrated (47) . The results of the present study have demonstrated a close association of biglycan with the extracellular matrix and this interaction may be mediated through other matrix molecules, such as fibronectin, that might bind this molecule to collagen. We have not observed biglycan in epithelium of adult human gingiva, in contrast to those found in developing human dermal tissue (9). We suggest that the biglycan expression in epithelium could be differently regulated in adult tissue compared with developing tissue and that biglycan expression in gingival and dermal epithelium may also be different.
Large chondroitin sulfate PG has been previously isolated from human gingival connective tissue (44) . With immunohistochemical methods, chondroitin sulfate has also been shown to have widespread distribution in human gingival connective tissue (48) . In this study we have observed that the large molecular weight PG is a prominent component of human periodontal tissues. The distribution of this PG was opposite to that of decorin, accumulating in deep connective tissue areas between collagen fiber bundles. The suggested function of the large molecular weight PGs is to provide elasticity to tissues (23). Areas of deep connective tissue in human gingiva contain large amounts of Type I collagen fibers (52) which, in association with large molecular weight PGs, could provide mechanical resilience to the tissue. In addition, the core protein of large molecular weight PG contains a hyaluronic acid-binding region (5) through which it could form large molecular size aggregates with hyaluronic acid, thus occupying the space in the gingival tissues.
The function and composition of the periodontal ligament extracellular matrix are different from those of gingival connective tissue. The major GAG in periodontal ligament include hyaluronic acid, chondroitin sulfate, dermatan sulfate, and heparan sulfate (55) . Decorin and a large molecular weight PG have been shown to be the major PGs of periodontal ligament (11, 56) . Cells from this tissue synthesize decorin and versican, and CD44 in culture (18) . Periodontal ligament fibroblasts also express biglycan mRNA in vitro (321). The periodontal ligament serves to balance the compressive forces transmitted from teeth to supportive structures. Similar to deep connective tissue areas of gingiva, we observed intense staining of the large molecular weight PG in the periodontal ligament. We suggest an additional role for this PG in regulating the elastic properties of the periodontal ligament. The ratio of collagen Type I to Type 111 in periodontal ligament is decreased compared with gingiva, and the metabolic rate of this tissue is high (31). Decorin might play a role in this area in tissue remodeling and collagen fiber assembly. Although periodontal ligament fibroblasts express biglycan mRNA in culture (3,21), we were able to show only very weak staining of the periodontal ligament with an antibody against biglycan. A zone relatively free of any PGs was demonstrated under the junctional epithelium, suggesting that this area is structurally different from other parts of the connective tissue.
CD44 is expressed in vivo in several tissues, including human epidermis and dermis (26). Gingival keratinocytes (H. Larjava et al., unpublished observation) and periodontal fibroblasts (18) express CD44 in vitro. In this study CD44 was localized in oral epithelium and on fibroblasts in gingival and periodontal ligament connective tissues. Similar to epidermis (26), CD44 was localized in cell-cell contact areas of basal and spinous layers of oral epithelium. Hyaluronic acid, the proposed ligand for CD44 (27), has been demonstrated in cell-cell interfaces at a similar location in gingival epithelium (57) . Therefore, CD44 could serve as a receptor for hyaluronic acid in gingival epithelium. Interestingly, the junctional epithelium was relatively devoid of CD44. Phenotypical differences between oral and junctional epithelia have been reported (58) , which might account for the differences in expression of CD44 by these tissues. Similar to dermal connective tissue (26), CD44 was localized on fibroblasts in periodontal connective tissue. In addition to binding hyaluronic acid (27), CD44 can serve as a receptor for collagen and fibronectin (59) . Localization of CD44 in periodontal connective tissue suggests a similar function for this receptor in periodontal fibroblasts.
The findings in the present study that various parts of human periodontal tissues contain typical compositions of PGs suggest a different functional role for various PGs in periodontal homeostasis.
